A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 4.57 USD -5.38% Market Closed
Market Cap: 416.1m USD
Have any thoughts about
Aquestive Therapeutics Inc?
Write Note

Aquestive Therapeutics Inc
Net Issuance of Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aquestive Therapeutics Inc
Net Issuance of Debt Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
A
Aquestive Therapeutics Inc
NASDAQ:AQST
Net Issuance of Debt
-$8.9m
CAGR 3-Years
N/A
CAGR 5-Years
-75%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Net Issuance of Debt
$8.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
40%
Bristol-Myers Squibb Co
NYSE:BMY
Net Issuance of Debt
$12.6B
CAGR 3-Years
N/A
CAGR 5-Years
-7%
CAGR 10-Years
37%
Pfizer Inc
NYSE:PFE
Net Issuance of Debt
$4.2B
CAGR 3-Years
N/A
CAGR 5-Years
-16%
CAGR 10-Years
15%
Merck & Co Inc
NYSE:MRK
Net Issuance of Debt
$2.8B
CAGR 3-Years
N/A
CAGR 5-Years
2%
CAGR 10-Years
7%
Eli Lilly and Co
NYSE:LLY
Net Issuance of Debt
$10.5B
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
45%

See Also

What is Aquestive Therapeutics Inc's Net Issuance of Debt?
Net Issuance of Debt
-8.9m USD

Based on the financial report for Jun 30, 2024, Aquestive Therapeutics Inc's Net Issuance of Debt amounts to -8.9m USD.

What is Aquestive Therapeutics Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
-75%

Over the last year, the Net Issuance of Debt growth was 40%.

Back to Top